CA2352564A1 - Use of effectors of the central cholinergic nervous system - Google Patents

Use of effectors of the central cholinergic nervous system Download PDF

Info

Publication number
CA2352564A1
CA2352564A1 CA002352564A CA2352564A CA2352564A1 CA 2352564 A1 CA2352564 A1 CA 2352564A1 CA 002352564 A CA002352564 A CA 002352564A CA 2352564 A CA2352564 A CA 2352564A CA 2352564 A1 CA2352564 A1 CA 2352564A1
Authority
CA
Canada
Prior art keywords
effectors
nervous system
central cholinergic
cholinergic nervous
central
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002352564A
Other languages
French (fr)
Other versions
CA2352564C (en
Inventor
Peter Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanochemia Pharmazeutika AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2352564A1 publication Critical patent/CA2352564A1/en
Application granted granted Critical
Publication of CA2352564C publication Critical patent/CA2352564C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Abstract

The invention relates to the use of effectors of the central cholinergic nervous system for the production of a preparation to treat non-anticholinergic delirium.
CA002352564A 1998-11-27 1999-11-22 Use of effectors of the central cholinergic nervous system Expired - Fee Related CA2352564C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT199598 1998-11-27
ATA1995/98 1998-11-27
PCT/AT1999/000284 WO2000032185A1 (en) 1998-11-27 1999-11-22 Use of effectors of the central cholinergic nervous system

Publications (2)

Publication Number Publication Date
CA2352564A1 true CA2352564A1 (en) 2000-06-08
CA2352564C CA2352564C (en) 2009-05-19

Family

ID=3525562

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002352564A Expired - Fee Related CA2352564C (en) 1998-11-27 1999-11-22 Use of effectors of the central cholinergic nervous system

Country Status (9)

Country Link
EP (1) EP1133290B1 (en)
JP (1) JP4422342B2 (en)
AU (1) AU768331B2 (en)
CA (1) CA2352564C (en)
DE (1) DE59904564D1 (en)
ES (1) ES2168240T3 (en)
GR (1) GR20010300072T1 (en)
NZ (1) NZ512546A (en)
WO (1) WO2000032185A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10301851A1 (en) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Use of dialkylaminoalkylphenyl carbamate derivatives to protect humans from poisoning by cholinesterase inhibitors, including pesticides and chemical warfare agents
AT414125B (en) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag NEW DERIVATIVES OF 4A, 5,9,10,11,12-HEXAHYDRO-BENZOFURO (3A, 3,2) (2) BENZAZEPINE, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE PRODUCTION OF MEDICAMENTS
WO2005030332A2 (en) * 2003-09-29 2005-04-07 Sanochemia Pharmazeutika Ag Use of galanthamine and the derivatives thereof in the production of medicaments
US20080114027A1 (en) * 2006-11-09 2008-05-15 Johnson Kirk W Method for treating delirium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821957A3 (en) * 1996-08-01 1998-04-22 Eli Lilly And Company Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
WO1998017214A1 (en) * 1996-10-23 1998-04-30 Eli Lilly And Company Method for treating dementia due to aids
WO1998031356A1 (en) * 1997-01-17 1998-07-23 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
GR20010300072T1 (en) 2001-12-31
ES2168240T3 (en) 2003-11-16
EP1133290B1 (en) 2003-03-12
DE59904564D1 (en) 2003-04-17
NZ512546A (en) 2002-11-26
JP2002531401A (en) 2002-09-24
AU768331B2 (en) 2003-12-11
EP1133290A1 (en) 2001-09-19
AU1252900A (en) 2000-06-19
WO2000032185A1 (en) 2000-06-08
JP4422342B2 (en) 2010-02-24
ES2168240T1 (en) 2002-06-16
CA2352564C (en) 2009-05-19

Similar Documents

Publication Publication Date Title
AU4098096A (en) 2,8-disubstituted quinazolinones
AU5490199A (en) Process for the purification of 1,3-propanediol
AU6310696A (en) Substituted dihydrodibenz/b,f/azepines useful for treating nervous system disorders
EP1820790A3 (en) 3-Alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and process for making them
ZA97869B (en) Production of vinylidene olefins.
AU2717999A (en) Process for the production of gamma-butyrolactone
CA2300405A1 (en) Use of cholinesterase inhibitors for treating attention deficit disorders
AU2515399A (en) Process for the production of gamma-butyrolactone
CA2201762A1 (en) Method for purifying keratinocyte growth factors
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
CA2352564A1 (en) Use of effectors of the central cholinergic nervous system
ZA99477B (en) Process for the preparation of (-)CIS-3-Hydroxy-1-Methyl-4-(2,4,6-Trimethoxyphenyl)Piperidine.
AU3330699A (en) Process for the production of microcapsules
AU6780298A (en) Production of 1,3-diaminopentane by hydrogenation of 3-aminopentanenitrile
BG103649A (en) Method for the preparation of eprosartan
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
GB2343892B (en) Process for the preparation of d,l-menthol
BG103650A (en) Method for the preparation of eprosartan
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU4912799A (en) Process for the production of mannitol by immobilized micro-organisms
ZA968550B (en) Novel processes for the preparation of anti-malarial compounds.
AU2781597A (en) Improved process for the production of scratch-off cards
AU7773700A (en) Method for the production or preparation of 2,6-dichlorotoluol
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
CA2328832A1 (en) Processes for preparing pesticidal intermediates

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed